Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 19, 2015 17:05 ET | Source: Acasti Pharma Inc.

Acasti Announces Grant of Stock Options

LAVAL, Quebec, Aug. 19, 2015 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti" or the "Corporation") (NASDAQ:ACST) (TSX-V:APO), an emerging biopharmaceutical company focused on the research,...
July 13, 2015 17:05 ET | Source: Acasti Pharma Inc.

Acasti Announces First Quarter Results

LAVAL, Quebec, July 13, 2015 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti" or the "Corporation") (NASDAQ:ACST) (TSX-V:APO), an emerging biopharmaceutical company focused on the research,...
June 01, 2015 07:30 ET | Source: Acasti Pharma Inc.

Acasti Announces Grant of Stock Options

LAVAL, Quebec, June 1, 2015 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti" or the "Corporation") (Nasdaq:ACST) (TSX-V:APO), an emerging biopharmaceutical company focused on the research, development...
May 27, 2015 17:37 ET | Source: Acasti Pharma Inc.

Acasti Announces Fourth Quarter and Fiscal Year Results

LAVAL, Quebec,, May 27, 2015 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti" or the "Corporation") (Nasdaq:ACST) (TSX-V:APO), an emerging biopharmaceutical company focused on the research,...
May 27, 2015 17:35 ET | Source: Acasti Pharma Inc.

Acasti Announces New Board of Director Nominees for Election at Annual and Special Meeting of Shareholders

LAVAL, Quebec, May 27, 2015 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti" or the "Corporation") (Nasdaq:ACST) (TSX-V:APO), an emerging biopharmaceutical company focused on the research, development...
May 11, 2015 10:48 ET | Source: Acasti Pharma Inc.

Acasti Receives Extension to Regain Compliance With NASDAQ Minimum Bid Price Rule

LAVAL, Quebec, May 11, 2015 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti" or the "Corporation") (Nasdaq:ACST) (TSX-V:APO), an emerging biopharmaceutical company focused on the research, development...
April 29, 2015 18:34 ET | Source: Acasti Pharma Inc.

Acasti Announces Departure of Chief Financial Officer

LAVAL, Quebec, April 29, 2015 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti" or the "Corporation") (Nasdaq:ACST ) (TSX-V:APO), an emerging biopharmaceutical company focused on the research,...
March 25, 2015 07:30 ET | Source: Acasti Pharma Inc.

Acasti Granted Composition & Use Patent in China

LAVAL, Quebec, March 25, 2015 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti" or the "Corporation") (Nasdaq:ACST) (TSX-V:APO), an emerging biopharmaceutical company focused on the research,...
March 02, 2015 07:30 ET | Source: Acasti Pharma Inc.

Acasti Receives Full Data for Phase II TRIFECTA Trial

LAVAL, Quebec, March 2, 2015 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti" or the "Corporation") (Nasdaq:ACST) (TSX-V:APO), an emerging biopharmaceutical company focused on the research,...
January 13, 2015 17:05 ET | Source: Acasti Pharma Inc.

Acasti Announces Third Quarter Results

LAVAL, Quebec, Jan. 13, 2015 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti" or the "Corporation") (Nasdaq:ACST) (TSX-V:APO), an emerging biopharmaceutical company focused on the research,...